CollPlant Biotechnologies Ltd. (NASDAQ:CLGN – Free Report) – Analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for CollPlant Biotechnologies in a note issued to investors on Friday, April 5th. HC Wainwright analyst S. Ramakanth anticipates that the company will post earnings of ($0.36) per share for the quarter. HC Wainwright currently […]
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN – Get Free Report) was the recipient of a large decline in short interest during the month of December. As of December 15th, there was short interest totalling 11,500 shares, a decline of 18.4% from the November 30th total of 14,100 shares. Based on an average trading volume of 14,800 shares, […]
HC Wainwright reaffirmed their buy rating on shares of CollPlant Biotechnologies (NASDAQ:CLGN – Free Report) in a research note issued to investors on Thursday morning, Benzinga reports. They currently have a $11.00 target price on the stock. CollPlant Biotechnologies Price Performance NASDAQ CLGN opened at $5.35 on Thursday. CollPlant Biotechnologies has a 1-year low of […]
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN – Get Free Report)’s share price traded up 0.3% during trading on Tuesday . The company traded as high as $5.70 and last traded at $5.68. 13,581 shares traded hands during trading, a decline of 1% from the average session volume of 13,698 shares. The stock had previously closed at $5.66. […]
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN – Get Free Report) saw a significant drop in short interest in September. As of September 30th, there was short interest totalling 36,100 shares, a drop of 15.3% from the September 15th total of 42,600 shares. Approximately 0.5% of the company’s stock are sold short. Based on an average daily trading […]